Profile: Hemosense, Inc. develops, manufactures & sells handheld blood coagulation monitoring systems used by patients and healthcare professionals. Our product line incudes INRatio®system, INRatio®monitor, INRatio2®monitor & INRatio®teststrip. Our INRatio®system measures the patient’s blood clotting time, & maintains the therapeutic range with the proper dosage of oral anticoagulant therapy. Our INRatio®monitor is a diagnostic point of care system that provides prothrombin time (PT), & international normalized ratio (INR) result, using fresh capillary whole blood from a finger prick. It reduces the hassles of oral anticoagulation management. Our INRatio®teststrip is compatible with both the INRatio and the INRatio2 monitor. The test strip is made up of laminated layers.
The company has revenues of < USD 1 Million, has ~20 employees and is CE certified. AMEX:IMA (SEC Filings)
3 Products/Services (Click for related suppliers)
|
• Blood Coagulation Systems |
• Prothrombin Time Test (FDA Code: GJS / 864.7750) A prothrombin time test is a device used as a general screening procedure for the detection of possible clotting factor deficiencies in the extrinsic coagulation pathway, which involves the reaction between coagulation factors III and VII, and to monitor patients receiving coumarin therapy (the administration of one of the coumarin anticoagulants in the treatment of venous thrombosis or pulmonary embolism). |
• Testing Strips |